Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol

Clinical trial NCT00768274 · COMPLETED

Trial details

NCT number: NCT00768274
Sponsor: Resverlogix Corp
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Dyslipidemia Atherosclerosis Acute Coronary Syndrome Cardiovascular Disease

Start date: 2008-09-01
Primary completion: 2009-08-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.